A SERVICE IMPROVEMENT OPPORTUNITY FOR PHARMACIST INDEPENDENT PRESCRIBERS? A LITERATURE REVIEW EXAMINING THE RELATIONSHIP BETWEEN POOR DIABETES CONTROL AND THE CO-EXISTENCE OF MENTAL HEALTH ISSUES
DOI:
https://doi.org/10.22159/ijcpr.2019v11i4.34930Keywords:
Depression, Type 2 Diabetes, Diabetes, Independent Prescribing Pharmacist, PharmacistAbstract
Diabetes and mental illness are clinically managed by diverse pathways. However, an association between the two has been observed and evidence is growing that when poorly addressed, therapy adherence is low and outcomes are poor. To date, no intervention has been shown to provide sustained improvements in adherence, outcome, quality of life or provider cost savings. This literature review was undertaken as a foundation to a research project to examine whether there is an opportunity for current independent prescriber pharmacists, with or without further training, could as part of a primary care team, contribute their expertise to achieving better and sustainable outcomes for these conditions, where current treatment models are heavily medication-dependent. It reinforces the idea that these conditions are interlinked but by poorly understood mechanisms and suggests that a new approach is required in order to improve outcomes for this complex patient group.
Downloads
Download data is not yet available.
References
1. Charles EF, Lambert CG, Kerner B. Bipolar disorder and diabetes mellitus: evidence for disease-modifying effects and treatment implications. Int J Bipolar Disord 2016;4:13.
2. Harkness E, MacDonald W, Valderas J, Coventry P, Gask L, Bower P. Identifying psychosocial interventions that improve both physical and mental health in patients with diabetes a systematic review and meta-analysis. Diabetes Care 2010;33:926-30.
3. NICE Guideline NG18. Diabetes (type 1 and type 2) children and young people: diagnosis and management. National Institute for Health and Care Excellence; 2016. Available from: https://www.nice.org.uk/guidance/ng18/chapter/Introduction. [Last accessed on 10 Oct 2018]
4. NICE guidance and current practice report. Mental Health. National Institute for Health Care Excellence UK; 2017. Available from: https://webcache.googleusercontent.com/search?q=cache:vE98mZ1x9SUJ: https://www.nice.org.uk/media/default/about/what-we-do/into-practice/measuring-uptake/nice-guidance-and-current-practice-report-mental-health. pdf+andcd=1andhl=enandct=clnkandgl=uk. [Last accessed on 10 Oct 2018]
5. Beka Q, Bowker S, Savu A, Kingston D, Johnson AJ, Kaul P. Development of perinatal mental illness in women with gestational diabetes mellitus: a population-based cohort study. Can J Diabetes 2018;42:350-5.
6. NICE Guidelines NG28 Type 2 Diabetes in adult management. National Institute for Health Care Excellence UK; 2017. Available from:https://www.nice.org.uk/guidance/ng28/chapter/Introduction [Last accessed on 10 Oct 2018]
7. Kruse J, Schmitz N, Thefeld W. On the association between diabetes and mental disorders in a community sample. Diabetes Care 2003;26:1841-6.
8. Hein M, Lanquart JP, Loas G, Hubain P, Linkowski P. Prevalence and risk factors of type 2 diabetes in major depression: a study on 703 individuals referred to sleep examination. Psychosomatics 2018;59:144-57.
9. Shin JK, Shortridge Baggett LM, Sachmechici I, Barron C, Chiu YL, Bajracharya B, et al. Screening for type 2 diabetes mellitus in patients with mental illness: application of a self-assessment score for diabetes mellitus risk. Psychiatry Res 2014;220:1037-42.
10. Huang CJ, Wang SY, Lee MH, Chiu HC. Prevalence and incidence of mental illness in diabetes: a national population-based cohort study. Diab Res Clin Pract 2011;93:106-14.
11. Sajatovic M, Gunzler D, Einstadter D, Thomas C, McCormick R, Perzynski AT, et al. A preliminary analysis of individuals with serious mental illness and comorbid diabetes. Arch Psychiatr Nurs 2016;30:226-9.
12. Sajatovic M, Gunzler DD, Kanuch SW, Cassidy KA, Tatsuoka C, McCormick R, et al. A 60-week prospective RCT of a self-managed intervention for individuals with serious mental illness and diabetes mellitus. Psychiatr Serv 2017;68:883-90.
13. Gron AO, Dalsgaard EM, Ribe AR, Seidu S, Mora G, Cebrian Cuenca AM, et al. Improving diabetes care among patients with severe mental illness: a systematic review of the effect of an intervention. Primary Care Diabetes 2018;12:289-304.
14. Belvederi Murri M, Mamberto S, Briatore L, Mazzucchelli C, Amore M, Cordera R. The interplay between diabetes, depression and affective temperaments: a structural equation model. J Affect Disord 2017;219:64-71.
15. Telo GH, Cureau FV, Lopes CS, Schaan BD. Common mental disorder in adolescents with and without type 1 diabetes: reported occurrence from a countrywide survey. Diabetes Res Clin Pract 2017;135:192-8.
16. Solanki V, Ball PA, Morrissey H. Disease-modifying the effect of type 2 diabetes mellitus and bipolar disorder comorbidity. Int J Curr Med Pharm Res 2018;4:2253-3261.
17. Nasker S, Victor R, Nath K. Depression in diabetes mellitus-A comprehensive systematic review of literature from an Indian perspective. Asian J Psychiatr 2017;27:85-100.
18. Robinson DJ, Coons M, Haensel H, Vallis M, Yale JF. Diabetes and mental health. Diabetes canada clinical practice guidelines expert committee. Can J Diabetes 2018;42(s1):S130-S141.
19. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001;24:1069-78.
20. Ogawa M, Miyamoto Y, Kawakami N. Factors associated with glycemic control and diabetes self-care among outpatients with schizophrenia and type 2 diabetes. Arch Psychiatr Nurs 2011;25:63-73.
21. Dickerson FB, Ricard MPH, Goldberg W, Brown CH, Krevenbuhl JA, Wohlheiter KMS, et al. Diabetes knowledge among persons with serious mental illness and type 2 diabetes. Psychosomatics 2005;46:418-24.
22. Glasgow RE. Outcomes of and for diabetes education research. Diabetes Educ 1999;25(Suppl 6):74-88.
23. Musselman DL, Betan E, Larsen H, Phillips LS. Relationship of depression to diabetes types 1 and 2 epidemiology, biology and treatment. Biol Psychiatry 2003;54:317-29.
24. Hayward C. Psychiatric illness and cardiovascular disease risk. Epidemiol Rev 1995;17:129-38.
25. Pendlebury J, Holt R. Managing diabetes in people with severe mental illness. J Diabetes Nurs 2010;14:328-39.
26. Fagiolini A, Goracci A. The effects of undertreated chronic medical illnesses in patients with severe mental disorders. J Clin Psychiatry 2009;70(Suppl 3):22-9.
27. Hajek T, Calkin C, Blagdon R, Slaney C, Alda M. Type 2 diabetes mellitus: a potentially modifiable risk factor for neurochemical brain changes in bipolar disorders. Biol Psychiatr 2015;77:295-303.
28. Beavers K, Leng I, Rapp S, Miller M, Houston D, Marsh A, et al. Effects of longitudinal glucose exposure on cognitive and physical function: results from the action for health in diabetes movement and memory study. J Am Geriatr Soc 2016;65:137-45.
29. Convit A. Links between cognitive impairment in insulin resistance: an explanatory model. Neurobiol Aging 2005;26(s1):31-5.
30. Bjorgaas M, Gimse R, Vik T, Sand T. Cognitive function in type 1 diabetic children with and without episodes of severe hypoglycaemia. Acta Pediatr 1997;86:148-53.
31. Gradman TJ, Laws A, Thompson LW, Reaven GM. Verbal learning and/or memory improves with glycemic control in older subjects with non-insulin-dependent diabetes mellitus. J Am Geriatr Soc 1993;41:1305-12.
32. Goldberg RW, Kreyenbuhl JA, Medoff DR, Dickerson FB, Wohlheiter K, Fang LJ, et al. Quality of diabetes care among adults with serious mental illness. Psychiatr Serv 2007;58:536-43.
33. De Hert M, Dekker JM, Wood D, Kahl KG, Holt RI, MöllerHJ. Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC). Eur Psychiatry 2009;24:412-24.
34. Mclyntyre RS, KonarskiJ Z, Misener VL, Kennedy SH. Bipolar disorder and diabetes mellitus: epidemiology, aetiology and treatment implication. Ann Clin Psychiatry 2005;17:83-93.
35. Ismail K, Winkley K, Rabe Hesketh S. Systematic review and meta-analysis of randomised controlled trials of psychological interventions to improve glycaemic control in patients with type 2 diabetes. Lancet 2004;363:1589-97.
36. Wang MY, Tsai PS, Chou KR, Chen CM. A systematic review of the efficacy of non-pharmacological treatments for depression on glycaemic control in type 2 diabetics. J Clin Nurs 2008;17:2524-30.
37. Baumeister H, Hutter N, Bengel J. Psychological and pharmacological interventions for depression in patients with diabetes mellitus and depression. Cochrane Database Systematic Rev 2012;12:CD008381.
38. Lunghi C, Zongo A, Moison J, Gregoire JP, Guenette L. The impact of incident depression on medication adherence in patients with type 2 diabetes. Diabetes Metab 2017;43:521-8.
39. Gorczynski P, Patel H, Ganguli R. Adherence to diabetes medication in individuals with schizophrenia: a systematic review of rates and determinants of adherence. Clin Schizophre Relat Psychoses 2017;10:191-200.
40. Lunghi C, Moisan J, Gregoire JP, Guenette L. Incidence of depression and associated factors in patients with type 2 diabetes in quebec, canada: a population-based cohort study. Medicine (Baltimore) 2016;95:e3514.
41. Gentil L, Vasiliadi HM, Preille M, Berbiche D. Adherence to oral antihyperglycemic agents among older adults with mental disorders and its effect on health care costs, Quebec, Canada 2005-2008. Prev Chronic Dis 2015;12:E230.
42. Gonzalez JS, Peyrot M, McCarl LA, Collins EM, Matthews LS, Mimiaga J, et al. Depression and diabetes treatment nonadherence: a meta-analysis. Diabetes Care 2008;31:2398-403.
2. Harkness E, MacDonald W, Valderas J, Coventry P, Gask L, Bower P. Identifying psychosocial interventions that improve both physical and mental health in patients with diabetes a systematic review and meta-analysis. Diabetes Care 2010;33:926-30.
3. NICE Guideline NG18. Diabetes (type 1 and type 2) children and young people: diagnosis and management. National Institute for Health and Care Excellence; 2016. Available from: https://www.nice.org.uk/guidance/ng18/chapter/Introduction. [Last accessed on 10 Oct 2018]
4. NICE guidance and current practice report. Mental Health. National Institute for Health Care Excellence UK; 2017. Available from: https://webcache.googleusercontent.com/search?q=cache:vE98mZ1x9SUJ: https://www.nice.org.uk/media/default/about/what-we-do/into-practice/measuring-uptake/nice-guidance-and-current-practice-report-mental-health. pdf+andcd=1andhl=enandct=clnkandgl=uk. [Last accessed on 10 Oct 2018]
5. Beka Q, Bowker S, Savu A, Kingston D, Johnson AJ, Kaul P. Development of perinatal mental illness in women with gestational diabetes mellitus: a population-based cohort study. Can J Diabetes 2018;42:350-5.
6. NICE Guidelines NG28 Type 2 Diabetes in adult management. National Institute for Health Care Excellence UK; 2017. Available from:https://www.nice.org.uk/guidance/ng28/chapter/Introduction [Last accessed on 10 Oct 2018]
7. Kruse J, Schmitz N, Thefeld W. On the association between diabetes and mental disorders in a community sample. Diabetes Care 2003;26:1841-6.
8. Hein M, Lanquart JP, Loas G, Hubain P, Linkowski P. Prevalence and risk factors of type 2 diabetes in major depression: a study on 703 individuals referred to sleep examination. Psychosomatics 2018;59:144-57.
9. Shin JK, Shortridge Baggett LM, Sachmechici I, Barron C, Chiu YL, Bajracharya B, et al. Screening for type 2 diabetes mellitus in patients with mental illness: application of a self-assessment score for diabetes mellitus risk. Psychiatry Res 2014;220:1037-42.
10. Huang CJ, Wang SY, Lee MH, Chiu HC. Prevalence and incidence of mental illness in diabetes: a national population-based cohort study. Diab Res Clin Pract 2011;93:106-14.
11. Sajatovic M, Gunzler D, Einstadter D, Thomas C, McCormick R, Perzynski AT, et al. A preliminary analysis of individuals with serious mental illness and comorbid diabetes. Arch Psychiatr Nurs 2016;30:226-9.
12. Sajatovic M, Gunzler DD, Kanuch SW, Cassidy KA, Tatsuoka C, McCormick R, et al. A 60-week prospective RCT of a self-managed intervention for individuals with serious mental illness and diabetes mellitus. Psychiatr Serv 2017;68:883-90.
13. Gron AO, Dalsgaard EM, Ribe AR, Seidu S, Mora G, Cebrian Cuenca AM, et al. Improving diabetes care among patients with severe mental illness: a systematic review of the effect of an intervention. Primary Care Diabetes 2018;12:289-304.
14. Belvederi Murri M, Mamberto S, Briatore L, Mazzucchelli C, Amore M, Cordera R. The interplay between diabetes, depression and affective temperaments: a structural equation model. J Affect Disord 2017;219:64-71.
15. Telo GH, Cureau FV, Lopes CS, Schaan BD. Common mental disorder in adolescents with and without type 1 diabetes: reported occurrence from a countrywide survey. Diabetes Res Clin Pract 2017;135:192-8.
16. Solanki V, Ball PA, Morrissey H. Disease-modifying the effect of type 2 diabetes mellitus and bipolar disorder comorbidity. Int J Curr Med Pharm Res 2018;4:2253-3261.
17. Nasker S, Victor R, Nath K. Depression in diabetes mellitus-A comprehensive systematic review of literature from an Indian perspective. Asian J Psychiatr 2017;27:85-100.
18. Robinson DJ, Coons M, Haensel H, Vallis M, Yale JF. Diabetes and mental health. Diabetes canada clinical practice guidelines expert committee. Can J Diabetes 2018;42(s1):S130-S141.
19. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001;24:1069-78.
20. Ogawa M, Miyamoto Y, Kawakami N. Factors associated with glycemic control and diabetes self-care among outpatients with schizophrenia and type 2 diabetes. Arch Psychiatr Nurs 2011;25:63-73.
21. Dickerson FB, Ricard MPH, Goldberg W, Brown CH, Krevenbuhl JA, Wohlheiter KMS, et al. Diabetes knowledge among persons with serious mental illness and type 2 diabetes. Psychosomatics 2005;46:418-24.
22. Glasgow RE. Outcomes of and for diabetes education research. Diabetes Educ 1999;25(Suppl 6):74-88.
23. Musselman DL, Betan E, Larsen H, Phillips LS. Relationship of depression to diabetes types 1 and 2 epidemiology, biology and treatment. Biol Psychiatry 2003;54:317-29.
24. Hayward C. Psychiatric illness and cardiovascular disease risk. Epidemiol Rev 1995;17:129-38.
25. Pendlebury J, Holt R. Managing diabetes in people with severe mental illness. J Diabetes Nurs 2010;14:328-39.
26. Fagiolini A, Goracci A. The effects of undertreated chronic medical illnesses in patients with severe mental disorders. J Clin Psychiatry 2009;70(Suppl 3):22-9.
27. Hajek T, Calkin C, Blagdon R, Slaney C, Alda M. Type 2 diabetes mellitus: a potentially modifiable risk factor for neurochemical brain changes in bipolar disorders. Biol Psychiatr 2015;77:295-303.
28. Beavers K, Leng I, Rapp S, Miller M, Houston D, Marsh A, et al. Effects of longitudinal glucose exposure on cognitive and physical function: results from the action for health in diabetes movement and memory study. J Am Geriatr Soc 2016;65:137-45.
29. Convit A. Links between cognitive impairment in insulin resistance: an explanatory model. Neurobiol Aging 2005;26(s1):31-5.
30. Bjorgaas M, Gimse R, Vik T, Sand T. Cognitive function in type 1 diabetic children with and without episodes of severe hypoglycaemia. Acta Pediatr 1997;86:148-53.
31. Gradman TJ, Laws A, Thompson LW, Reaven GM. Verbal learning and/or memory improves with glycemic control in older subjects with non-insulin-dependent diabetes mellitus. J Am Geriatr Soc 1993;41:1305-12.
32. Goldberg RW, Kreyenbuhl JA, Medoff DR, Dickerson FB, Wohlheiter K, Fang LJ, et al. Quality of diabetes care among adults with serious mental illness. Psychiatr Serv 2007;58:536-43.
33. De Hert M, Dekker JM, Wood D, Kahl KG, Holt RI, MöllerHJ. Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC). Eur Psychiatry 2009;24:412-24.
34. Mclyntyre RS, KonarskiJ Z, Misener VL, Kennedy SH. Bipolar disorder and diabetes mellitus: epidemiology, aetiology and treatment implication. Ann Clin Psychiatry 2005;17:83-93.
35. Ismail K, Winkley K, Rabe Hesketh S. Systematic review and meta-analysis of randomised controlled trials of psychological interventions to improve glycaemic control in patients with type 2 diabetes. Lancet 2004;363:1589-97.
36. Wang MY, Tsai PS, Chou KR, Chen CM. A systematic review of the efficacy of non-pharmacological treatments for depression on glycaemic control in type 2 diabetics. J Clin Nurs 2008;17:2524-30.
37. Baumeister H, Hutter N, Bengel J. Psychological and pharmacological interventions for depression in patients with diabetes mellitus and depression. Cochrane Database Systematic Rev 2012;12:CD008381.
38. Lunghi C, Zongo A, Moison J, Gregoire JP, Guenette L. The impact of incident depression on medication adherence in patients with type 2 diabetes. Diabetes Metab 2017;43:521-8.
39. Gorczynski P, Patel H, Ganguli R. Adherence to diabetes medication in individuals with schizophrenia: a systematic review of rates and determinants of adherence. Clin Schizophre Relat Psychoses 2017;10:191-200.
40. Lunghi C, Moisan J, Gregoire JP, Guenette L. Incidence of depression and associated factors in patients with type 2 diabetes in quebec, canada: a population-based cohort study. Medicine (Baltimore) 2016;95:e3514.
41. Gentil L, Vasiliadi HM, Preille M, Berbiche D. Adherence to oral antihyperglycemic agents among older adults with mental disorders and its effect on health care costs, Quebec, Canada 2005-2008. Prev Chronic Dis 2015;12:E230.
42. Gonzalez JS, Peyrot M, McCarl LA, Collins EM, Matthews LS, Mimiaga J, et al. Depression and diabetes treatment nonadherence: a meta-analysis. Diabetes Care 2008;31:2398-403.
Published
15-07-2019
How to Cite
BIBI, N., H. MORRISSEY, and P. BALL. “A SERVICE IMPROVEMENT OPPORTUNITY FOR PHARMACIST INDEPENDENT PRESCRIBERS? A LITERATURE REVIEW EXAMINING THE RELATIONSHIP BETWEEN POOR DIABETES CONTROL AND THE CO-EXISTENCE OF MENTAL HEALTH ISSUES”. International Journal of Current Pharmaceutical Research, vol. 11, no. 4, July 2019, pp. 6-10, doi:10.22159/ijcpr.2019v11i4.34930.
Issue
Section
Review Article(s)
